Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0690
Source ID: NCT01580046
Associated Drug: Iodixanol
Title: Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
Acronym: RIPE
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Kidney Failure, Chronic
Interventions: DRUG: iodixanol|DRUG: iopromide
Outcome Measures: Primary: to evaluate the change in Glomerular Filtration Rate levels by Estimated Glomerular Filtration Rate, days 3 and 7 | Secondary: In each group(Iodixanol group and Iopromide group), the proportion of patients exhibiting an increases of serum creatinine in different range(<10%,10%~25%, and ≥25%), comparing with baseline level., days 3 and 7|Incidence of hemodialysis, days 3 and 7|Changes of Cystatin C level from baseline, days 1 and 3
Sponsor/Collaborators: Sponsor: Yong Huo
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 200
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Start Date: 2012-04
Completion Date: 2013-12
Results First Posted:
Last Update Posted: 2013-10-16
Locations: Anhui Provincial Hospital, Hefei, Anhui, 230001, China|Peking University First Hospital, Beijing, Beijing, 100044, China|Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China|Guangdong Academy Of Medical Sciences Guangdong General Hospital, Guangzhou, Guangdong, 510080, China|The First Affiliated Hospital Of Guangxi Medical University, Nanning, Guangxi, 530021, China|The People's Hospital Of Hebei Province, Shijiazhuang, Hebei, 050051, China|Henan Provincial People's Hospital, Luoyang, Henan, 450000, China|The Second Affiliated Hospital To Nanchang University, Nanchang, Jiangxi, 330006, China|The People's Hospital Of Liaoning Province, Shenyang, Liaoning, 110016, China|The Affiliated Hospital Of Medical College Qingdao University, Qingdao, Shandong, 266003, China|Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, 030024, China|Peking University People's Hospital, Beijing, 100044, China|Pla Navy General Hospital, Beijing, 100048, China|The Central Hospital Of China Aerospace Corporation, Beijing, 100049, China|Chinese PLA General Hospital, Beijing, 100853, China|Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China|Renji Hospital ，Shanghai Jiao Tong University School Of Medicine, Shanghai, 200001, China|Shanghai Chest Hospital Affiliated To Shanghai Jiaotong University, Shanghai, 200030, China|Shanghai First People's Hospital, Shanghai, 200080, China
URL: https://clinicaltrials.gov/show/NCT01580046

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress